XML 50 R30.htm IDEA: XBRL DOCUMENT v3.22.4
Stock-Based Compensation​ (Tables)
12 Months Ended
Dec. 31, 2022
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Award, Employee Stock Purchase Plan, Valuation Assumptions The following table sets forth the key assumptions and fair value results for each award granted in the Company’s first offering period under the ESPP, which started on December 1, 2022:
December 1, 2022
Stock price$2.58 
Risk-free interest rate4.65 %
Term (in years)0.50
Volatility87.00 %
Dividend yield0.00 %
Grant date fair value per share$1.00 
Share-based Payment Arrangement, Option, Activity
A summary of the Company’s stock option activity is as follows:
Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
(In millions)
Outstanding as of January 1, 20229,444,221 $0.12 8.66$55.9 
Exercised(3,644,154)0.12 12.8 
Expired/forfeited(464,093)0.11 
Outstanding as of December 31, 2022
5,335,974 0.12 7.669.4 
Exercisable as of December 31, 2022
1,080,723 $0.13 7.77$1.9 
Vested and expected to vest as of December 31, 2022
5,335,974 0.12 7.669.4 
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The assumptions used in the Black-Scholes option pricing model to estimate the fair value of the stock options granted during the year of December 31, 2021 are provided in the following table:
December 31, 2021
Risk-free interest rate:
Employee stock options0.62 %
Non-employee stock options1.08 %
Expected term (in years):
Employee stock options6.32
Non-employee stock options10.00
Expected volatility:
Employee stock options87.94 %
Non-employee stock options88.03 %
Dividend yield:
Employee stock options0.00 %
Non-employee stock options0.00 %
Grant date fair value per share:
Employee stock options$13.65 
Non-employee stock options$13.68 
Share-based Payment Arrangement, Restricted Stock Unit, Activity
A summary of the Company’s restricted stock activity is as follows:
Number of
Shares
Weighted
Average
Grant Price
Outstanding as of January 1, 202236,249,396 $6.53 
Granted13,710,027 3.35 
Vested(5,269,553)4.78 
Forfeited (1,543,238)6.79 
Outstanding as of December 31, 2022
43,146,632 5.72 
Schedule of Share-Based Payment Award, Equity Instruments Other Than Options, Valuation Assumptions
The following assumptions were used to estimate the fair value, using the Monte Carlo simulation, of the market award grant:

September 16, 2021
Stock price$9.92 
Term (in years)7
Volatility55.00 %
Risk-free interest rate1.13 %
Dividend yield0.00 %
Share-based Payment Arrangement, Expensed and Capitalized, Amount
The following table presents stock-based compensation expense included in each respective expense category in the consolidated statements of operations (in millions):
Year Ended December 31,
20222021
Research and development$26.1 $3.7 
General and administrative76.7 119.9 
Total stock-based compensation expense$102.8 $123.6 
Share-based Payment Arrangement, Warrant Activity
A summary of the Company’s warrant activity is as follows:
Number of
Shares
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life (Years)
Aggregate
Intrinsic
Value
(In millions)
Outstanding as of January 1, 20228,644,932 $0.01 8.87$52.1 
Issued91,667 0.01 
Outstanding as of December 31, 2022
8,736,599 0.01 7.8416.3 
Vested as of December 31, 2022
3,576,981 $0.01 4.59$6.7